Procurement Summary
Country: Brazil
Summary: Acquisition of Medicines to Meet Legal Demands with and Without Trademark Determination.
Deadline: 14 Jul 2026
Posting Date: 29 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 144190039
Document Ref. No.: 90297/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of Medicines to meet Legal Demands with and without Commercial Brand Determination. UASG code: 90201 Notice from: 06/29/2026 from 08:00 to 12:00 and from 13:00 to 17:59 Proposal Delivery: from 06/29/2026 at 08:00 DIPIRONE SODIUM, COMPOSITION ASSOCIATED WITH CAFFEINE AND DIHYDROERGOTAMINE, CONCENTRATION 350 MG + 100 MG + 1 MG Quantity: 180 DIPIRONE SODIUM, COMPOSITION ASSOCIATED WITH ADIFENINE AND PROMETAZINE, CONCENTRATION 500MG + 10MG + 5MG Quantity: 540 BETAMETHASONE, DIPROPIONATE COMPOSITION, DOSAGE 0.64MG/G, CREAM USE Quantity: 180 ENALAPRIL MALEATE, PRESENTATION ASSOCIATED WITH HYDROCHLOROTHIAZIDE, ADDITIONAL CHARACTERISTICS 20MG + 12.5MG Quantity: 180 SCOPOLAMINE BUTYLBROMIDE, PRESENTATION ASSOCIATED WITH PARACETAMOL, DOSAGE 10MG + 500MG Quantity: 540 SCOPOLAMINE BUTYLBROMIDE, DOSAGE 10 MG/ML, INDICATION FOR ORAL SOLUTION Quantity: 540 ESTRADIOL, COMPOSITION 17-BETA ESTRADIOL, CONCENTRATION 0.6 MG/G, GEL PHARMACEUTICAL FORM, ADDITIONAL FEATURE WITH DOSING RULER Quantity: 240 CONJUGATED ESTROGENS, DOSAGE 0.625 MG Quantity: 180 FENOTEROL BROMYDRATE, CONCENTRATION 5 MG/ML, PHARMACEUTICAL FORM, ORAL SOLUTION Quantity: 360 PHENOXYMETHYLPENICILLIN, POTASSIUM COMPOSITION, CONCENTRATION 80, 000IU/ML, ORAL SOLUTION PRESENTATION Quantity: 1080 ELEMENTAL IRON, CONCENTRATION 60 MG Quantity: 180 IRON TRISGLYCINATE, CONCENTRATION 500 MG, PHARMACEUTICAL FORM CHEWABLE TABLET Quantity: 180 FEXOFENADINE, CONCENTRATION 6 MG/ML, PHARMACEUTICAL FORM ORAL SUSPENSION Quantity: 1440 SALMETEROL XINAFOATE, COMPOSITION ASSOCIATED WITH FLUTICASONE PROPIONATE, CONCENTRATION 25 MCG + 50 MCG/DOSE, PHARMACEUTICAL FORM ORAL SPRAY Quantity: 720 FLUTICASONE, PROPIONATE COMPOSITION, CONCENTRATION 50MCG/DOSE, PHARMACEUTICAL FORM ORAL AEROSOL - SPRAY Quantity: 1440 GAL...
Documents
Tender Notice